Search
for
Sort by
Research 361–390 of 1000+
- Formulation and Evaluation of Hair Gel Containing Leaf Extract of Mussaenda Frondosa
- Determination of adulteration in hair serums by LC-HRMS §
- Telogen effluvium and associated incidence of abnormal serum ferritin, zinc, 25-hydroxy vitamin D, and thyroid-stimulating hormone
- Pay-For-Delay Settlements in theWake of Actavis
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus
- Treatment of Hair Loss
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy
- Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
- Structural characterization of cyclosporin A, C and microbial bio-transformed cyclosporin A analog AM6 using HPLC–ESI–ion trap-mass spectrometry
- Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women
- Effects of 5-alpha reductase inhibitors
- Finasteride-Induced Neuropsychiatric Reactions
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Efficacy and safety of topical 5% minoxidil in treatment of androgenetic alopecia
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- News in brief
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Dermatological adverse events with taxane chemotherapy
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Adverse effects of common medications on male fertility
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth